Work

Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.12322

Authors: S. Sha, D. Polidori, T. Heise, J. Natarajan, K. Farrell, S.‐S. Wang, D. Sica, P. Rothenberg, L. Plum‐Mörschel

Institutions: Janssen Research & Development (United States), Profil Institute for Metabolic Research, Virginia Commonwealth University Medical Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Mitsubishi Tanabe Pharma Corporation

OpenAlex ID: W2024878386

FWCI: 13.95

Cites: 31

Cited by: 250

Related to: 10